ARTICLE | Company News
Ethypharm, Meda deal
August 13, 2007 7:00 AM UTC
MEDA received exclusive rights to market a ketoprofen/omeprazole combination product in certain European territories to treat pain and inflammation. Ethypharm received E3 million ($4.1 million) up fro...